Regular extended release morphine for chronic breathlessness: a multi-centre double-blind RCT
D. Currow (Sydney, Australia), S. Louw (Sydney, Australia), P. Mccloud (Sydney, Australia), B. Fazekas (Sydney, Australia), J. Plummer (Adelaide, Australia), C. Mcdonald (Adelaide, Australia), M. Agar (Sydney, Australia), K. Clark (Sydney, Australia), N. Mccaffrey (Melbourne, Australia), A. Abernethy (North Carolina, United States of America), M. Ekstrom (Lund, Sweden)
Source: International Congress 2018 – Best abstracts in pulmonary rehabilitation and chronic care
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
D. Currow (Sydney, Australia), S. Louw (Sydney, Australia), P. Mccloud (Sydney, Australia), B. Fazekas (Sydney, Australia), J. Plummer (Adelaide, Australia), C. Mcdonald (Adelaide, Australia), M. Agar (Sydney, Australia), K. Clark (Sydney, Australia), N. Mccaffrey (Melbourne, Australia), A. Abernethy (North Carolina, United States of America), M. Ekstrom (Lund, Sweden). Regular extended release morphine for chronic breathlessness: a multi-centre double-blind RCT. 1624
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
A randomized double-blind placebo-controlled trial on the short and long-term effects of electro acupuncture on moderate to severe asthma Source: Eur Respir J 2006; 28: Suppl. 50, 502s Year: 2006
Acute effects of nasal high-flow during exercise in COPD patients after an exacerbation : a randomized controlled cross-over trial Source: International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies Year: 2019
Antibiotic in non-purulent hospitalised-treated exacerbations of COPD: a randomised double-blind placebo-controlled trial Source: International Congress 2019 – Airway infection in COPD Year: 2019
Efficacy of a short course of oral prednisolone for acute preschool viral-wheeze: a double-blind randomised placebo-controlled trial with stratification for systemic eosinophil priming Source: Eur Respir J 2003; 22: Suppl. 45, 388s Year: 2003
Working memory training efficacy in COPD: the randomised, double-blind, placebo-controlled Cogtrain trial Source: ERJ Open Res, 7 (4) 00475-2021; 10.1183/23120541.00475-2021 Year: 2021
The effect of bronchodilators in the exercise capacity and thoracoabdominal mechanics of subjects with bronchiectasis: a randomized crossover, double-blinded, placebo-controlled trial Source: Virtual Congress 2020 – Exercise tolerance and functional status across respiratory diseases Year: 2020
Chinese herbs in treatment of postinfectious cough: A multi-centre, randomized, double-blind, placebo-controlled trial Source: Annual Congress 2013 –New drugs in respiratory medicine Year: 2013
Effects of ghrelin on the dyspnea pattern in cachectic COPD: Exploratory analysis of a substudy of a multicenter, randomized, double-blind, placebo-controlled trial of ghrelin treatment Source: Annual Congress 2013 –Respiratory and cardiovascular abnormalities in COPD: the role of exercise, nutritional status and inflammation Year: 2013
Gefapixant in two randomised dose-escalation studies in chronic cough Source: Eur Respir J, 55 (3) 1901615; 10.1183/13993003.01615-2019 Year: 2020
Late Breaking Abstract - The impact of regular bisoprolol on recovery with salbutamol in asthma; a double-blind randomised controlled trial Source: International Congress 2019 – Asthma treatment: novel insights from clinical studies Year: 2019
Sertraline in symptomatic chronic breathlessness: a double blind, randomised trial Source: International Congress 2018 – Let’s interact and discuss the hot topics in pulmonary rehabilitation Year: 2018
Sertraline in symptomatic chronic breathlessness: a double blind, randomised trial Source: Eur Respir J, 53 (1) 1801270; 10.1183/13993003.01270-2018 Year: 2019
BAY 2253651 for the treatment of obstructive sleep apnoea: a multicentre, double-blind, randomised controlled trial (SANDMAN) Source: Eur Respir J, 58 (5) 2101937; 10.1183/13993003.01937-2021 Year: 2021
RCT Abstract - Randomized, double-blind, placebo-controlled, phase III clinical trial with MV130, a sublingual bacterial immunotherapy to prevent COPD exacerbations Source: Virtual Congress 2021 – ALERT: COPD Year: 2021
Omalizumab efficacy following cat allergen exposure: Results from a randomized, double-blind, placebo-controlled, parallel-group study in patients with moderate asthma Source: Annual Congress 2010 - Asthma: clinical aspects and treatment Year: 2010
A randomized, double-blind, placebo-controlled study to evaluate the role of formoterol in management of acute asthma Source: Eur Respir J 2006; 28: Suppl. 50, 498s Year: 2006
A double-blind randomised controlled trial of protein supplementation to enhance exercise capacity in COPD during pulmonary rehabilitation: a pilot study Source: ERJ Open Res, 7 (1) 00077-2021; 10.1183/23120541.00077-2021 Year: 2021
Can simvastatin reduce COPD exacerbations? A randomised double-blind controlled study Source: Eur Respir J, 58 (1) 2001798; 10.1183/13993003.01798-2020 Year: 2021
Impact of oral clonidine on duration of opioid and benzodiazepine use in mechanically ventilated children: a randomized, double-blind, placebo-controlled study Source: Virtual Congress 2020 – Neonatal and paediatric intensive care: diagnosis, management and outcomes Year: 2020